GCT team is pleased to announce the end of subject screening for a relapsing-remitting multiple sclerosis trial in Russia.
In total 243 patients were screened by 21 participating sites in 9-month period.
Dec 4, 2015
GCT team is pleased to announce the end of subject screening for a relapsing-remitting multiple sclerosis trial in Russia.
In total 243 patients were screened by 21 participating sites in 9-month period.